To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.
Summary
What This Bill Does
Requires States seeking Substance Use Prevention, Treatment, and Recovery Services block grants to include more information in their State plans about medication-assisted treatment availability, diversion controls, misuse data, and drug-screening protocols.
Who Benefits and How
Congress, HHS, and oversight stakeholders would receive more standardized information about how States manage medication-assisted treatment and related misuse risks in block-grant-funded systems of care.
Who Bears the Burden and How
State agencies administering the block grants would need to gather and report additional operational and misuse data in their plans, which can add reporting and monitoring work.
Key Provisions
- Adds a new State-plan element for the Substance Use Prevention, Treatment, and Recovery Services block grant.
- Requires descriptions of the types of medication-assisted-treatment drugs available in the State system of care.
- Requires reporting on diversion-prevention and enforcement protocols, misuse data, and drug-screening protocols for medication-assisted-treatment patients.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Requires States seeking Substance Use Prevention, Treatment, and Recovery Services block grants to include more information in their State plans about medication-assisted treatment availability, diversion controls, misuse data, and drug-screening protocols.
Key Policy Areas
Health, Public Health, State Government
Primary Purpose
Requires States seeking Substance Use Prevention, Treatment, and Recovery Services block grants to include more information in their State plans about medication-assisted treatment availability, diversion controls, misuse data, and drug-screening protocols.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Federal and congressional overseers seeking more detailed State medication-assisted-treatment information
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- State substance-use agencies preparing expanded block grant plan submissions
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
IntroducedMrs. Houchin introduced the following bill; which was referred to …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology